PHILADELPHIA, May 19, 2026 /PRNewswire/ -- After a twelve-year legal battle, the United States Supreme Court today denied Eli Lilly and Company's petition for a writ of certiorari, finalizing a judgment of more than $220 million against the pharmaceutical giant. The decision cements a massive victory for whistleblower Ronald J. Streck and his legal team at Walden Macht Haran & Williams LLP (WMHW) and Martin Law, P.C., who successfully litigated this False Claims Act case from start to finish.
The Supreme Court's denial leaves in place the September 2025 unanimous decision by the Seventh Circuit Court of Appeals, which affirmed the August 2022 unanimous jury verdict. Following a trial in the Northern District of Illinois, a jury found Eli Lilly liable for defrauding the Medicaid Drug Rebate Program, and the district court entered a judgment that, with accumulated interest, now exceeds $220 million. This is believed to be the first jury verdict against a pharmaceutical company under the federal False Claims Act, a statute that has been on the books for over 160 years.
Dan Miller, WMHW Partner and lead counsel for Mr. Streck, commented on today's development:
"This denial by the Supreme Court is the final word in a twelve-year fight for justice. Lilly exhausted every possible avenue to avoid accountability, but the facts and the law prevailed at every single level—from the jury box in Chicago, to the Seventh Circuit, and now the highest court in the land. This is a...
; ; New discussions around pension reforms have gained momentum after Cabinet Secretary TV Somanathan assured the National Council-Joint Consultative Machinery (NC-JCM) that recommendations relate...